Stryker

Stryker moves innovation through regulatory approval and into the market at a notable pace. FDA clearances define their commercial profile more than any other signal, showing a company that turns product development into market-ready output. Active M&A adds technology capability alongside that output. Their patent portfolio spans a wide range of technology domains, with every asset fully active and built on well-constructed inventions.